|
|
||||||||
APPETITE, OBESITY, DIGESTION, AND METABOLISM
1Department of Nutritional Sciences, University of Wisconsin-Madison, Madison, Wisconsin; and 2Department of Medical Physiology, Panum Institute, University of Copenhagen, Copenhagen, Denmark
Submitted 9 April 2007 ; accepted in final form 6 February 2008
Luminal nutrients stimulate structural and functional regeneration in the intestine through mechanisms thought to involve insulin-like growth factor I (IGF-I) and glucagon-like peptide-2 (GLP-2). We investigated the relationship between IGF-I and GLP-2 responses and mucosal growth in rats fasted for 48 h and then refed for 2 or 4 days by continuous intravenous or intragastric infusion or ad libitum feeding. Fasting induced significant decreases in body weight, plasma concentrations of IGF-I and bioactive GLP-2, jejunal mucosal cellularity (mass, protein, DNA, and villus height), IGF-I mRNA, and ileal proglucagon mRNA. Plasma IGF-I concentration was restored to fed levels with 2 days of ad libitum refeeding but not with 4 days of intravenous or intragastric refeeding. Administration of an inhibitor of endogenous GLP-2 (rat GLP-23–33) during ad libitum refeeding partially attenuated mucosal growth and prevented the increase in plasma IGF-I to fed levels; however, plasma GLP-2 and jejunal IGF-I mRNA were restored to fed levels. Intragastric refeeding restored intestinal cellularity and functional capacity (sucrase activity and sodium-glucose transporter-1 expression) to fed levels, whereas intravenous refeeding had no effect. Intestinal regeneration after 4 days of intragastric or 2 days of ad libitum refeeding was positively associated with increases in plasma concentrations of GLP-2 and jejunal IGF-I mRNA. These data suggest that luminal nutrients stimulate intestinal growth, in part, by increased expression of both GLP-2 and IGF-I.
parenteral nutrition; proglucagon; sodium-glucose linked transporter-1; GLP-23–33
This article has been cited by other articles:
![]() |
M. C. Koopmann, X. Liu, C. J. Boehler, S. G. Murali, J. J. Holst, and D. M. Ney Colonic GLP-2 is not Sufficient to Promote Jejunal Adaptation in a PN-Dependent Rat Model of Human Short Bowel Syndrome JPEN J Parenter Enteral Nutr, November 1, 2009; 33(6): 629 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu, S. G. Murali, J. J. Holst, and D. M. Ney Whey protein potentiates the intestinotrophic action of glucagon-like peptide-2 in parenterally fed rats Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2009; 297(5): R1554 - R1562. [Abstract] [Full Text] [PDF] |
||||
![]() |
P D Cani, S Possemiers, T Van de Wiele, Y Guiot, A Everard, O Rottier, L Geurts, D Naslain, A Neyrinck, D M Lambert, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability Gut, August 1, 2009; 58(8): 1091 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu, S. G. Murali, J. J. Holst, and D. M. Ney Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1794 - R1802. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |